Jon Cuthbert

Flagship Minerals (ASX:FLG) has agreed to sell its total stake in a Thailand lithium project for US$4 million.

Uniswap (CRYPTO:UNI) has launched a no-code token auction tool within the Uniswap Web App.

Middle East conflict disruptions will reduce Worley (ASX:WOR) financial year 2026 underlying earnings by up to $60 million.

Aave (CRYPTO:AAVE) could reach US$3,500 by the end of 2030, according to a new forecast from Standard Chartered, which said growth in decentralised finance could support higher demand for the lending protocol's native token.

The a2 Milk Company (ASX:A2M) declared a NZ$300 million special dividend after securing regulatory approvals in China.

Methode Electronics (NYSE:MEI) reported fourth-quarter fiscal 2026 net sales of $298.1 million, representing a 15.9% increase compared with the same period last year.

ALZpath has entered a global licensing agreement with Abbott (NYSE:ABT) to support the development of an in vitro diagnostic blood test for Alzheimer’s disease using its proprietary pTau217 antibody.

Kaspi.kz (NASDAQ:KSPI) received regulatory approval from Türkiye’s Banking Regulation and Supervision Agency (BDDK) to acquire Rabobank A.Ş., a fully licensed Turkish bank.

Cognition Therapeutics (NASDAQ:CGTX) reported FDA alignment on key elements of a pivotal Phase 3 trial of zervimesine (CT1812) for the treatment of psychosis in dementia with Lewy bodies (DLB).

CalciMedica (NASDAQ:CALC) reported that the U.S. Food and Drug Administration reviewed a protocol amendment and interim safety data from its Phase 2 KOURAGE trial and provided no comments, allowing dosing to continue.